查詢結果分析
來源資料
相關文獻
- Omeprazole Plus Amoxicillin Versus Triple Therapy Eradicates Helicobacter Pylori in the Chinese with Peptic Ulcer Disease
- Randomized Controlled Trial of Omeprazole Plus Amoxicillin vs. Triple Therapy for Eradication of Helicobacter pylori
- 幽門螺旋桿菌之消除與消化性潰瘍之治療
- 消化性潰瘍的元兇--幽門螺旋桿菌
- 醇提大黃對消化性潰瘍合併幽門螺旋桿菌感染之作用探討
- 幽門螺旋桿菌根除治療對消化性潰瘍復發的效益評估
- 含Lansoprazole雙重或三合療法治療十二指腸潰瘍合併幽門螺旋桿菌感染之效果比較
- C丨 Urea Breath Test Combined with Symptomatology is Helpful in Deciding Which Dyspeptic Patients Need Endoscopy to Rule in Peptic Ulcer
- Current Treatment of Helicobacter Pylori Infection and Peptic Ulcer Disease
- Clarithromycin in the Combination Therapy for the Eradication of Helicobacter Pyloriin Peptic Ulcer Disease
頁籤選單縮合
題 名 | Randomized Controlled Trial of Omeprazole Plus Amoxicillin vs. Triple Therapy for Eradication of Helicobacter pylori=三合療法與Omeprazole併Amoxicillin治療幽門螺旋桿菌之隨機對照試驗 |
---|---|
作 者 | 林憲宏; 黃英哲; 黃呂津; 姚介和; 趙哲仁; | 書刊名 | 慈濟醫學 |
卷 期 | 7:2 1995.06[民84.06] |
頁 次 | 頁105-109 |
分類號 | 415.526 |
關鍵詞 | 消化性潰瘍; 幽門螺旋桿菌; 三合療法; 二合療法; Helicobacter pylori; Peptic ulcer; Triple therapy; Dual therapy; |
語 文 | 英文(English) |
中文摘要 | 本院曾報告以三合療法治幽門螺旋桿菌在花蓮成效甚佳。以Omeprazole 併amoxicillin據報告亦有不錯的效果。為比較二者,特進行隨機對照試驗。自1994 年1至4月,計有胃或十二指腸潰瘍且胃黏膜CLO試驗陽性患者97例進入試驗。所 有患者均以第二型組織胺受體拮抗劑治療消化性潰瘍,同時並接受幽門螺旋桿菌 治療,計O組48例(omeprazole 20 mg bid及amoxicillin 500mg gid共14日),T組49例 (colloidal bismuth subcitrate 120 mg,tetracycline 250mg,metronidazole 250 mg每日四次 共14日)。停藥28日以上作胃鏡追蹤。兩組各有11及8例未回診或未吃抗生素,各 有19及26例抗生素服用不完全或拒作追蹤胃鏡,因此最後只分別有18及15例可以 作比較。計男21、女12例,平均53.6歲,CLO試驗陰轉率兩組各為72.2及80.0(P>0.1), 潰瘍癒合率為77.8及73.3。潰瘍未癒8例中:3例CLO陽性,1例使用NSAID,2例CLO 陽性且使用NSAID。T組有1例吃藥後頭腰痛、2例腹瀉,O組有2例腹瀉、1例便泌, 但均可將藥物按時服完。結論:以三合療法治幽門螺旋桿菌之消除率可達80.0,以 omeprazole併amoxicillin則為72.2,統計上無差異。兩種療法之耐受度均佳。(慈濟 醫學 1995;7:105-109) |
英文摘要 | Our previous study and many others have shown that triple therapy with colloidal bismuthsubcitrate, metronidazole, and tetracycline is effective in the treatment of Helicobacter pyloriinfection. The combination of omeprazole and amoxicillin has also been claimed to be effective,with earlier symptom relief and less side effects. To compare the efficacy of the two regimens, arandomized controlled study was performed. From January to April 1994, 97 successive patientswith endoscopically proven peptic ulcer and positive mucosal urease test results entered the study.Forty eight (48) patients were randomized to receive omeprazole 20 mg twice a day and amoxicillin 500 mg four times a day for 14 days (group O). The other 49 patients were assigned totake colloidal bismuth subcitrate 120 mg, tetracycline 250 mg, and metronidazole 250 mg eachfour times a day for 14 days (group T). Upper endoscopy was performed again at least 28 daysafter completion of treatment. There were 30 cases in group 0 and 34 cases in group T who didnot take the medications as instructed or who refused to receive the second endoscopy aftercompletion of treatment, and were excluded for data analysis. Mucosal urease became negativein 72.2 of patients in group O, comparable to 80.0 in group T (P>0.1). Ulcers healed in 77.8in group O and 73.3 in group T. For group O, 2 patients had diarrhea during treatment andone complained of constipation. For group T, 2 patients complained of diarrhea, and one complained of headache and backache. In conclusion, omeprazole plus amoxicillin is as effective astriple therapy for the eradication of H pylori. The 20 to 30 drug resistance rate demands moreeffective treatment in the future. (TZU Chi Med J 1995; 7: 105-109) |
本系統中英文摘要資訊取自各篇刊載內容。